MedMira Inc. (TSXV: MIR)
Canada flag Canada · Delayed Price · Currency is CAD
0.130
+0.005 (4.00%)
Jan 21, 2025, 3:31 PM EST

MedMira Statistics

Total Valuation

MedMira has a market cap or net worth of CAD 87.72 million. The enterprise value is 102.22 million.

Market Cap 87.72M
Enterprise Value 102.22M

Important Dates

The last earnings date was Friday, January 3, 2025.

Earnings Date Jan 3, 2025
Ex-Dividend Date n/a

Share Statistics

MedMira has 701.73 million shares outstanding. The number of shares has increased by 0.50% in one year.

Current Share Class n/a
Shares Outstanding 701.73M
Shares Change (YoY) +0.50%
Shares Change (QoQ) +0.01%
Owned by Insiders (%) 0.40%
Owned by Institutions (%) n/a
Float 204.72M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 246.06
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -26.57
EV / Sales 286.78
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -25.59

Financial Position

The company has a current ratio of 0.13

Current Ratio 0.13
Quick Ratio 0.11
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF -3.89
Interest Coverage -3.22

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -39.59%
Return on Capital (ROIC) n/a
Revenue Per Employee 6,854
Profits Per Employee -73,971
Employee Count 52
Asset Turnover 0.07
Inventory Turnover 5.64

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +23.81% in the last 52 weeks. The beta is 10.29, so MedMira's price volatility has been higher than the market average.

Beta (5Y) 10.29
52-Week Price Change +23.81%
50-Day Moving Average 0.09
200-Day Moving Average 0.09
Relative Strength Index (RSI) 65.68
Average Volume (20 Days) 149,937

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, MedMira had revenue of CAD 356,429 and -3.85 million in losses. Loss per share was -0.01.

Revenue 356,429
Gross Profit -662,631
Operating Income -3.03M
Pretax Income -3.85M
Net Income -3.85M
EBITDA -2.97M
EBIT -3.03M
Loss Per Share -0.01
Full Income Statement

Balance Sheet

The company has 1.06 million in cash and 15.55 million in debt, giving a net cash position of -14.50 million or -0.02 per share.

Cash & Cash Equivalents 1.06M
Total Debt 15.55M
Net Cash -14.50M
Net Cash Per Share -0.02
Equity (Book Value) -19.34M
Book Value Per Share -0.03
Working Capital -18.68M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -3.25 million and capital expenditures -743,835, giving a free cash flow of -3.99 million.

Operating Cash Flow -3.25M
Capital Expenditures -743,835
Free Cash Flow -3.99M
FCF Per Share -0.01
Full Cash Flow Statement

Margins

Gross Margin -185.91%
Operating Margin -851.05%
Pretax Margin -1,079.18%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

MedMira does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.50%
Shareholder Yield -0.50%
Earnings Yield -4.80%
FCF Yield -4.55%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

MedMira has an Altman Z-Score of -33.64. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -33.64
Piotroski F-Score n/a